Financials

  • Market Capitalization 238.75 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.81
市销率
3.28

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3487
CLLS
Cellectis S.A. - American Depositary Shares
3.25 USD-1.52%-8.45%+13.64%+26.46%233.19 M USD
3489
RNA
Atrium Therapeutics, Inc. - Common Stock
14.06 USD+2.11%+1.52%+22.79%-80.01%240.51 M USD
3507
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
13.37 USD-4.36%-1.98%+31.59%-10.93%229.31 M USD
3509
TARA
Protara Therapeutics, Inc. - Common Stock
3.95 USD+1.28%+1.02%+0.25%+24.61%233.43 M USD

新闻